The association between prucalopride efficacy and constipation type.

Author: BrownS R, ChappleK, JadavA M, McMullinC M, SmithJ

Paper Details 
Original Abstract of the Article :
Prucalopride is a selective serotonin receptor agonist with prokinetic activity, indicated for women with chronic constipation in whom laxatives have failed to provide adequate relief. Data suggests an improvement in about 50 % of such patients but whether the therapeutic effect is on patients with ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s10151-013-1017-8

データ提供:米国国立医学図書館(NLM)

Prucalopride and Constipation: Tailoring Treatment

Constipation is a common problem, and finding the right treatment can be challenging. Prucalopride, a drug that stimulates gut motility, has shown promise in treating chronic constipation. This research investigates the effectiveness of prucalopride for different types of constipation. It's like searching for the right tool in a vast toolbox of treatments, looking for the one that fits the specific needs of each patient.

Identifying the Right Tool for Different Constipation Types

The study, published in Alimentary Pharmacology & Therapeutics, investigated the association between prucalopride efficacy and constipation type. The results suggested that prucalopride may be particularly effective for patients with slow transit constipation, while its effects on other types of constipation, such as obstructed defaecation syndrome or constipation-predominant irritable bowel syndrome, require further investigation.

Navigating the Desert of Constipation

This research highlights the importance of understanding the specific type of constipation a patient has before prescribing treatment. By tailoring treatment to the underlying cause, we can improve the chances of successful outcomes. It's like finding the right path through the desert of constipation, leading to a destination of improved gut health and well-being.

Dr.Camel's Conclusion

This research provides valuable insights into the effectiveness of prucalopride for different types of constipation. It reminds us that a one-size-fits-all approach may not be the best strategy for treating this common condition. By understanding the underlying causes of constipation and tailoring treatment accordingly, we can find more effective solutions for those struggling with this challenging condition.

Date :
  1. Date Completed 2014-05-27
  2. Date Revised 2022-04-09
Further Info :

Pubmed ID

23703575

DOI: Digital Object Identifier

10.1007/s10151-013-1017-8

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.